FGF21, a growth factor involved in different metabolic disorders and neurodegenerative disorders, exhibits neuroprotective effects against neurodegenerative diseases through inhibition of mitochondrial dysfunction, cerebrovascular aging, and associated inflammatory and oxidative stress disorders. This evidence concerns the gene FGF21 and metabolic disease.